CellSeed Inc.
JPX: 7776.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Setsuko Hashimoto
- Employees
- 44
- Headquarters
- Tokyo, Japan
- IPO year
- 2010
- Market cap
- ¥10.3B
- Website
- https://www.cellseed.com
Loading 7776…
Loading profile data…Frequently asked questions about 7776
What does CellSeed Inc. (7776.T) do?
CellSeed Inc. develops cell sheet regenerative medicines. It is involved in the research, development, and commercialization of cell-sheet regenerative medicine products, such as epithelial cell sheet for esophageal regeneration, regenerated cartilage sheet, and chondrocyte sheet for the treatment of knee osteoarthritis. The company also offers...
Where does 7776.T trade?
CellSeed Inc. (7776.T) trades on the Tokyo Stock Exchange.
What sector is 7776.T in?
CellSeed Inc. (7776.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CellSeed Inc.?
Setsuko Hashimoto is the chief executive officer of CellSeed Inc. (7776.T).
Where is CellSeed Inc. headquartered?
CellSeed Inc. is headquartered in Japan.
Does 7776.T pay a dividend?
CellSeed Inc. (7776.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 7776.T go public?
CellSeed Inc. (7776.T) completed its initial public offering in 2010.